Novo Nordisk (NVO)
(Delayed Data from NYSE)
$49.46 USD
-0.58 (-1.16%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $49.65 +0.19 (0.38%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVO 49.46 -0.58(-1.16%)
Will NVO be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NVO based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for NVO
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings
Other News for NVO
Earnings week ahead: AMD, PLTR, PFE, O, QCOM, ENB, SHOP, MCD, UBER, SMCI, BP, LCID, MRNA, ABNB, WBD, DKNG, AMC, and more
Trending stocks this week: Wall Street extends rally on Big Tech earnings, trade optimism, Fed rate cut
What You Missed On Wall Street On Friday
Stochastic Buy Signal appears for NVO after 1.16% move
Midday Fly By: Apple, Amazon upbeat reports lift Nasdaq